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Abstract
Background: In the mouse olfactory system, the role of the olfactory bulb in guiding olfactory
sensory neuron (OSN) axons to their targets is poorly understood. What cell types within the bulb
are necessary for targeting is unknown. What genes are important for this process is also unknown.
Although projection neurons are not required, other cell-types within the external plexiform and
glomerular layers also form synapses with OSNs. We hypothesized that these cells are important
for targeting, and express spatially differentially expressed guidance cues that act to guide OSN
axons within the bulb.
Results: We used laser microdissection and microarray analysis to find genes that are differentially
expressed along the dorsal-ventral, medial-lateral, and anterior-posterior axes of the bulb. The
expression patterns of these genes divide the bulb into previously unrecognized subdomains.
Interestingly, some genes are expressed in both the medial and lateral bulb, showing for the first
time the existence of symmetric expression along this axis. We use a regeneration paradigm to
show that several of these genes are altered in expression in response to deafferentation,
consistent with the interpretation that they are expressed in cells that interact with OSNs.
Conclusion: We demonstrate that the nascent external plexiform and glomerular layers of the
bulb can be divided into multiple domains based on the expression of these genes, several of which
are known to function in axon guidance, synaptogenesis, and angiogenesis. These genes represent
candidate guidance cues that may act to guide OSN axons within the bulb during targeting.
Background
In the mouse olfactory system, each olfactory sensory neu-
ron (OSN) extends an axon from the epithelium to the
olfactory bulb to form synapses within structures called
glomeruli [1]. The pattern of glomerular convergence is
remarkably stereotyped [2] and is strongly dependent
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upon the specific odorant receptor expressed by the OSN
[3,4]. But despite the number of cues that have been
found that are expressed by OSNs or along the path
traveled by OSNs to the bulb, surprisingly little is known
about the role of the olfactory bulb itself in this process
[5]. Transplantation and bulbectomy studies have
observed the formation of glomerular-like structures by
OSNs within cortical tissue [6]. Genetic ablation of mitral
and tufted projection neurons showed that topographi-
cally correct convergence by P2-expressing OSNs still
occurred in the absence of these target cells [7]. Disrup-
tion of the laminar nature of the mitral layer also did not
affect convergence by P2-expressing OSNs [8]. These
results have suggested that the olfactory bulb plays a min-
imal role, if any, in targeting [9,10].
On the other hand, studies ablating most of the bulb, as
opposed to eliminating only projection neurons, have
observed topographically incorrect convergence by P2-
expressing OSNs, suggesting a role for the bulb in deter-
mining the ultimate location of OSNs [11]. Tracing stud-
ies have long suggested the existence of zone-to-zone
mapping of OSNs onto corresponding domains within
the bulb [12]. In Drosophila,  Dscam  expression in the
antennal lobe is critical for proper olfactory receptor neu-
ron targeting [13], providing the first data that the target
structure is important for convergence. These experiments
in Drosophila suggest that the mammalian bulb may also
provide guidance information to OSNs [14]. Part of the
uncertainty surrounding the role of the bulb in guidance
is that it is unclear what other bulbar cells in addition to
mitral and tufted projection neurons could provide target-
ing information. While radial glia have long been sug-
gested as one possibility [7,15], cells in the external
plexiform (EPL) and glomerular (GL) layers also possess
many attractive characteristics. First, in addition to projec-
tion neurons, other cells in the EPL and GL form synapses
with OSNs [1]. Second, recent studies point to a diversity
of cell-types within these layers [16], and electrophysio-
logical studies have shown the presence of different types
of interneurons within the EPL [17]. Third, some glomer-
ular cell populations migrate into the bulb much earlier
than previously thought [18]. And finally, it has been
shown that external tufted cells indirectly connect glomer-
uli that are innervated by OSNs expressing a common
receptor [19]. Collectively, these data suggest that little is
known about the different sub-types and developmental
profiles of these cells. In one model, a subset of these EPL
and/or GL cells could provide guidance information to
OSNs. If this hypothesis is correct, then it should be pos-
sible to identify genes expressed by cells within these lay-
ers that are important for guidance and targeting.
Here we have undertaken a high resolution screen for
genes that spatially define distinct regions of the EPL and
GL. We used laser microdissection (LMD) coupled with
RNA amplification, microarrays, bioinformatics, and in
situ hybridization to search for genes that are differentially
expressed by cells within these layers. We identified 23
such cDNAs and show that the superficial layers of the
bulb can be subdivided into large regions based upon the
various expression patterns. The patterns demonstrate the
existence of gradients, localized expression domains, and
medial-lateral symmetry within the olfactory bulb. More-
over, these patterns are maintained in cells that do not
express Tbr1, consistent with the interpretation that they
are expressed in non-projection neurons. We further
show, using a chemical ablation paradigm, evidence con-
sistent with the interpretation that these genes are
expressed in cells that interact with OSNs.
Results
Spatial reconstruction of gene expression using laser 
microdissection
We performed our screen at embryonic day 17.5 (E17.5),
as this is the first time that convergence is observed in vivo
[20]. As the EPL and GL are not distinguishable at this
stage [21] our samples contained cells from both develop-
ing layers (Fig. 1). We will refer to the regions where these
samples were taken as the nascent EPL/GL. Only sections
up to the front of the accessory olfactory bulb were used.
These ~ 36 coronal sections were binned into three groups
corresponding to anterior, middle, and posterior bulb
(Fig. 1). As no prior genes have been identified as being
spatially differentially expressed within the nascent EPL/
GL, the size of each LMD sample, orientation, and loca-
tion was chosen based on the ability to easily separate
individual LMD samples. We also considered the known
pattern of glomerular innervation by OSNs, which is
shifted ~ 45° from vertical. We sampled cells from the
dorsolateral (DL), dorsomedial (DM), ventrolateral (VL),
and ventromedial (VM) nascent EPL/GL within each sec-
tion (Fig. 1). Three sections were chosen from each group
and four LMD isolates were obtained per section for a
total of 36 isolates. RNA was isolated from the ~ 30–50
cells within each sample, amplified, and applied to micro-
arrays [see Methods].
We synthesized the pool of microarray data into a three-
dimensional representation of gene expression within the
bulb [see Methods and Additional File 1]. As a result, all
33,000 cDNAs on the array could be queried to identify
those whose expression patterns indicate differential
expression within the bulb. For example, we examined
whether or not expression for any given gene was higher
or lower in the VM aspect relative to the remainder of the
bulb. Genes were grouped into four categories [see Addi-
tional File 1] and the top 12 from each were tested by in
situ hybridization. Of the 48 cDNAs, nine did not have
any detectable signal. Of the remaining 39, 20 were spa-BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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tially differentially expressed (51%). In one category (VL/
DL), 83% were spatially differentially expressed. These
results speak to the sensitivity of our analysis, as all sam-
ples differ essentially only by position. We also examined
a small subset of genes chosen based on annotation.
These genes, which were all ranked within the top 50,
were selected because they correspond to known, trans-
membrane-bound molecules. As such, they would be
more likely to directly interact with OSNs and influence
targeting. In total, 23 cDNAs were found to be spatially
varied in expression. As expected, all identified cDNAs
were differentially expressed within the nascent EPL/GL,
as confirmed by DAPI labeling and double-label in situ
hybridization (see below). Expression was not necessarily
exclusive to these layers, and was often observed in the
mitral layer as well.
Spatial differential expression of candidate cues at E17.5
We used GAP43 expression [22] and DAPI staining as con-
trols for our initial experiments. We found GAP43 to be
evenly distributed throughout the mitral and EPL layers
(Fig. 2A–B). DAPI staining showed that slightly more cells
are observed laterally in the anterior bulb, but in the mid-
dle and posterior bulb the distribution of cells appears
uniform (data not shown). These controls served to dis-
tinguish whether or not any of our observed in situ pat-
terns simply reflected the presence of increased numbers
of cells at a given location within the bulb.
We identified a diversity of patterns that are spatially dif-
ferentially expressed within the nascent EPL/GL. We
found that many of our positive cDNAs corresponded to
genes that are either secreted or are transmembrane-
bound proteins. Gicerin  is an immunoglobulin super-
family member that is a homophilic cell-adhesion mole-
cule [23]. Gicerin is expressed differentially in the lateral
aspect of the anterior bulb (Fig. 2C). However, not all cells
in this lateral domain express Gicerin, as the pattern
appears stippled. Expression is also observed in the nerve
layer. Strikingly, in the middle bulb, expression of Gicerin
appears symmetric in some areas about the ML and DV
axes, with high levels observed in the DM and VL bulb
(Fig. 2D). In more posterior bulb, these expression
domains gradually become connected with one another
along the DL surface, forming a crescent-shaped expres-
sion domain (data not shown). Expression in the VM
aspect, however, remains low throughout the AP extent of
the bulb.
Connective tissue growth factor, or CTGF [24], is a secreted
protein that is a member of a small family of genes which
interact with the extracellular matrix and growth factors,
and are important for angiogenesis [25]. In the anterior
bulb, CTGF is localized to the lateral aspect (Fig. 2E). Like
Gicerin, this expression is not uniform and significantly
higher expression occurs within a subset of these cells. In
the middle and posterior bulb, as with Gicerin, expression
is symmetric as higher CTGF expression is detected along
the DM and VL surfaces (Fig. 2F). CTGF is weaker in the
DL aspect and noticeably reduced in the VM bulb. CTGF
is also expressed in cartilage and connective tissue sur-
rounding the bulb.
Zinc finger csl-type containing 3 (Zcsl3) is a protein of
unknown function [26]. Throughout the AP axis, Zcsl3 is
expressed in a gradient-like pattern that extends from the
DM to the VL bulb (Fig. 2G), although expression tends to
shift more ventrally in the middle bulb (Fig. 2H).
Protocadherins have been shown to possess both
homophilic and heterophilic adhesion properties [27].
Protocadherin 17 (Pcdh17; [28]) is expressed throughout
the bulb, but is enhanced in the anterior bulb along the
VM aspect in a small subset of cells that extend into the
EPL (Fig. 2I). In the middle bulb, a small subset of cells in
the VL nerve layer expresses this gene (Fig. 2J). Protocad-
herin 7 (Pcdh7; [28]) is expressed anteriorly most strongly
along the medial aspect, although some signal can be seen
laterally (Fig. 2K). Just beyond the anterior bulb, this pat-
tern is reversed and Pcdh7  becomes strongest laterally,
Spatial reconstruction of gene expression using laser micro- dissection Figure 1
Spatial reconstruction of gene expression using laser 
microdissection. Above left – DAPI stain. Circled area 
indicates approximate size and cell number in each LMD 
sample. Left – nine sections were used for LMD that spanned 
the anterior, middle, and posterior bulb. Middle – four LMD 
samples were isolated from each section, sampling the DM, 
DL, VM, and VL aspects of the nascent EPL/GL. Right – RNA 
from each LMD sample was amplified and applied to microar-
rays. Bottom – data from the 36 arrays was synthesized to 
generate a three-dimensional statistical estimate of gene 
expression within the bulb for each gene on the array.BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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Spatially differentially expressed genes in E17.5 bulb Figure 2
Spatially differentially expressed genes in E17.5 bulb. Bulb sections are shown in pairs. The first column corresponds to 
anterior bulb and the second column corresponds to middle bulb. Medial is to the right and dorsal is towards the top. A-B) 
GAP43 expression is uniform within the EPL and mitral layers. C-D) Gicerin expression is primarily lateral in anterior bulb 
(arrowhead), with weak expression medially. In middle bulb, expression of Gicerin is symmetric, with signal in both VL and DM 
bulb (arrowheads). Weak expression connects these two domains here and in the posterior bulb (data not shown). E-F) Con-
nective tissue growth factor (CTGF) expression is similar to Gicerin anteriorly, with variable expression (arrowhead). In middle 
bulb, CTGF is symmetrically expressed (arrowheads) in the VL and DM domains, with weaker expression connecting the two 
domains. G-H) Zinc finger csl-type containing 3 (Zcsl3) is expressed in a gradient that extends from the dorsal to ventral, with 
highest expression along the VL aspect in anterior and middle bulb (arrowheads). I-J) Protocadherin17 expression is weakly 
present uniformly in the bulb, but regional higher expression can be observed in the VM aspect anteriorly (arrowhead). In the 
middle bulb, expression can be detected in the VL nerve layer (arrowhead). K-L) Protocadherin7 expression is strongest in the 
medial bulb anteriorly (arrowhead), but then moves towards the lateral surface in the middle bulb (arrowheads). Weaker 
expression is still present in the medial surface. M-N) Jagged1 expression in both anterior and middle bulb is symmetric about 
the ML axis (arrowheads). Note that this symmetry occurs only in the ventral bulb, unlike Gicerin and CTGF. O) Delta4 expres-
sion in the bulb is essentially restricted to the mitral layer (arrow). The section is counterstained with DAPI to show the loca-
tion of cells in the EPL. P) Higher magnification view of Jagged1 expression shown in 2N. Section has been counterstained with 
DAPI to show the location of cells in the EPL. Jagged1 expression extends into the EPL (arrow); compare with 2O. Scale bar = 
100 μm (2A-N); 25 μm (2O-P).BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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although some expression can still be detected medially
(Fig. 2L). This pattern is maintained throughout the pos-
terior bulb (data not shown).
Jagged1, a ligand for Notch, has been shown to be required
for proper endothelial branching during angiogenesis
[29]. In the anterior bulb, Jagged1  is symmetrically
expressed about the ML axis (Fig. 2M). Expression of
Jagged1 in these domains appears more even than that of
Gicerin or CTGF, and no obvious high or low-expressing
cells are observed within the expression domain. In the
middle bulb, Jagged1 maintains this ML symmetry, but
weaker expression connects the two subdomains (Fig.
2N). A similar pattern is observed in posterior bulb (data
not shown).
Although many of our genes are expressed in the nascent
mitral layer, we emphasize that at least some expressing
cells are located within the developing EPL. All of our in
situ hybridization experiments were counterstained with
DAPI so that we could correlate the location of the
observed signal with the position of the nascent mitral
and external plexiform layers. Delta4, another ligand for
Notch [30], is expressed primarily within the mitral layer,
and does not extend into the EPL (Fig. 2O). This can be
seen both by DAPI staining and by the relatively compact
expression pattern for this gene (Fig. 2O). Jagged1, on the
other hand, extends beyond the mitral layer into the EPL,
and its expression domain is broader than that of Delta4
(Fig. 2P). We further demonstrate that these genes are
expressed in the nascent EPL/GL using double-label exper-
iments and temporal analysis of their expression patterns,
as described below.
These expression patterns underscore the strong spatial
heterogeneity within the external plexiform layer. Moreo-
ver, they emphasize that there is variation along all three
axes of the bulb. They also show for the first time that the
bulb does indeed express genes that appear symmetric
about the ML axis.
A spatially differentially expressed putative microRNA
Among the remaining 17 cDNAs, significantly enhanced
expression was observed along the DV axis. The patterns
observed among all of these positives were remarkably
similar, and one representative example is shown in Fig-
ure 3. Within the nascent EPL/GL, these genes are
expressed in a punctate pattern (Figs. 3A–B). This punc-
tate expression occurs throughout the nascent EPL/GL,
but significantly fewer cells were labeled in the VM aspect
(compare Figs. 3A–B with Figs. 3A,3C).
Bioinformatic analysis showed that all 17 cDNAs con-
tained intronic or 3' untranslated sequence (Fig. 3G). Pair-
wise alignment identified a 134 basepair common ele-
ment that contained two microRNA (miRNA) sequences,
miR-706 and miR-709 (Fig. 3G). The remainder of the 134
bp element was ~ 95% identical to sequence immediately
upstream of the miR-706 sequence [31], corresponding to
what we assume is part of the primary miRNA (pri-
miRNA) sequence for miR-706 (Fig. 3H).
The expression pattern we observed may therefore reflect
the expression of miR-706  pri-miRNA. We obtained
locked nucleic acid (LNA)-modified oligos corresponding
to miR-706 and miR-138 (a control miRNA known to be
expressed in the bulb; [32]). We performed in situ hybrid-
ization with the LNA oligos as well as with the 134 base-
pair common element. Hybridization patterns using the
common element were identical to that observed with our
17 cDNAs (compare Fig. 3A with 3D). Although the signal
for the miR-706 probe was weaker than that of the com-
mon element, punctate signal was also observed in the
nascent EPL/GL in a similar pattern as well (compare Fig.
3A with 3E). These results contrast with those for the miR-
138 probe, which bound weakly and uniformly to the
nerve layer and EPL (Fig. 3F). The miRNA in situ patterns
that have been published in the mouse generally show
uniform expression within a given layer or structure (e.g.
miR-138), and/or are detected in specific cell-types. The
pattern of the miR-706 probe suggests, however, that miR-
NAs may also be present selectively within subsets of cells
in a spatially distinct fashion. Additional studies are
required to determine the possible targets of this putative
miRNA.
Three-dimensional reconstruction of gene expression
Our identified expression patterns show that the bulb can
be subdivided into different domains that are distin-
guished molecularly by the expression of these candidate
genes. These domains have not been previously described,
as only a handful of genes are known to be differentially
expressed within a given layer of the bulb [33-35]. We
were surprised by the complexity of the observed patterns,
as prior mapping studies had suggested the existence of
DV cues in the bulb [12], and theoretical models had sug-
gested the existence of symmetric cues to label medial and
lateral bulb [36]. Our observed expression patterns, how-
ever, do not readily fit any of these prior suggested mod-
els. For example, Gicerin symmetrically labels the DM and
VL bulb, but symmetry about these axes has not been pre-
viously predicted. To obtain a more detailed understand-
ing of the expression domains distinguished by these
individual genes, we generated a three-dimensional
reconstruction of gene expression for these genes within
the bulb.
To produce these recreations, coronal sections from E17.5
bulbs were obtained every 60–80 μm along the AP extent
of the bulb for every gene. The images of the hybridizedBMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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sections were combined using ImageJ [see Methods]. The
projection of the stacked images was then superimposed
upon a cartoon representation of the olfactory bulb for
ease of visualization. A subset of the images used to create
the Jagged1 and CTGF stacks are shown in Figure 4H–I,
and the corresponding reconstructions are shown in Fig-
ure 4E–F. Reconstructions of the other genes are also
shown in Figure 4. These reconstructions show that
domains of the bulb along the AP, DV, and ML axes can
be uniquely specified by the combinatorial expression of
these genes. These data support a model where molecular
heterogeneity in the nascent EPL/GL would provide spa-
tial guidance information to OSN axons as they converge
within the olfactory bulb.
Temporally dynamic expression of candidate cues during 
development – E14
The first OSNs are known to extend an axon towards the
developing bulb at E11–12, and "wait" at the periphery as
the bulb develops [37]. Sema3A expression at the periph-
ery of the bulb, expressed by ensheathing glia, plays a role
in maintaining OSNs outside of the bulb [38]. It is known
that mitral cell reorientation requires innervation by a
small population of early OSNs [21] that enter the bulb in
a medial-to-lateral progression [39]. Why this innervation
proceeds initially along the medial surface is not known.
One possibility would be that additional cues, in conjunc-
tion with Sema3A expression, serve to guide OSN axons to
their position within the bulb. We therefore examined the
expression of our candidate cues at E14 for differential
expression.
All of our identified genes are differentially expressed at
E14 in the superficial mantle layer. The putative miRNA
containing sequence, for example, is expressed strongly in
the DL bulb, with weak expression in the VM aspect (Fig.
5A). Gicerin is expressed more highly in the DL bulb as
well, with weak expression in VL bulb (Fig. 5B). CTGF, on
the other hand, is expressed more highly in the DM bulb
(Fig. 5C). Jagged1 is expressed more strongly in the ventral
aspect (Fig. 5D). Pcdh17 and Pcdh7 label complementary
domains (Fig. 5E–F). Pcdh17 strongly labels two popula-
tions of cells in the VM bulb, with lighter, more uniform
staining observed internally, and stronger, more selective
staining externally. Faint staining is also observed in the
DL bulb, symmetrically opposing the VM expression.
Pcdh7, in contrast, strongly labels a large number of cells
throughout the bulb except those along the VM surface.
Several of the observed patterns at E14 mimic those seen
at E17.5. For example, the putative miRNA is weakly
expressed in the VM bulb at both stages. Similarly, the
dual-layer expression of Pcdh17 in the VM bulb at E14 is
reflected at E17.5. Jagged1 is ventrally expressed at both
stages. On the other hand, other genes change in expres-
Common element expression Figure 3
Common element expression. Medial is to the right and 
dorsal is towards the top. A) E17.5 coronal bulb showing the 
typical punctate pattern observed with any one of 17 cDNA 
probes containing the common element. A) Signal is 
observed in the nascent EPL/GL, mitral, and granule layers. 
Weaker expression is observed in both the nascent EPL/GL 
and mitral layers along the VM surface (white box) as com-
pared to the rest of the bulb (e.g. black box). B) Higher mag-
nification of the black boxed area shown in (A). Note strong 
nuclear expression in nascent EPL/GL (arrowheads). C) 
Higher magnification of the white boxed area shown in (A). 
Note fewer cells and weaker staining as compared with (B). 
This is not due to a reduced number of cells in this area, as a 
significant number of nascent EPL/GL cells can be seen to be 
present that are unstained. D) Expression pattern using the 
134 bp common element as probe. E) Expression pattern 
using a dig-labeled LNA-oligo corresponding to miR-706. (D) 
and (E) are qualitatively similar to (A). F) Expression pattern 
using an LNA oligo for miR-138. The pattern is distinct from 
miR-706, with no punctate expression. Scale bar = 100 μm 
for A; 50 μm for C, D; 75 μm for D, E, F. G) The common 
element is contained within an intron or 3' untranslated 
region. Only a portion of the 134 bp conserved sequence is 
shown. Sequence contained within the element matches that 
of miR-709 at 17/19 positions (mismatches indicated by "+"). 
For miR-706, a subset of the cDNAs matched the sequence 
perfectly, with others matching at 21/22 or 20/22 positions. 
The most commonly observed mismatched nucleotide 
occurred at the 3' end (indicated by a "+"). H) The remainder 
of the element corresponds to sequence upstream of the 
presumed pri-miRNA (shown as dashed lines and filled cir-
cles) of miR-706.BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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sion between E14 and E17.5. Gicerin, for example, is
expressed most strongly at E14 in DL bulb, but at E17.5 is
present more strongly in the DM and VL bulb. CTGF also
shifts in expression along different axes from E14 to
E17.5, increasing in expression laterally and anteriorly as
development proceeds.
Temporally dynamic expression of candidate cues during 
development – P3
We next examined the expression of these various candi-
date cues at postnatal stages. While convergence has been
shown to occur at E17.5 for OSNs expressing the P2 odor-
ant receptor, other OSN populations do not converge
until later stages, up to postnatal day 3 [40,41]. The exist-
ence of relatively late converging OSNs prompted us to
examine the expression of these genes at P3.
At P3, Gicerin  is expressed in the anterior bulb more
highly in the lateral aspect (Fig. 6A). In the middle bulb,
expression can be seen in a complementary, symmetric
pattern (Fig. 6B). CTGF is also expressed differentially in
the lateral aspect of the anterior bulb (Fig. 6D), but in the
middle and posterior bulb, this expression becomes more
uniform (Fig. 6E). In contrast to Gicerin and CTGF, the
putative miRNA is now expressed uniformly within the
EPL (Fig. 6C). Similarly, Zcsl3 (Fig. 6F), Pcdh17 (Fig. 6H)
and Pcdh7 (Fig. 6I), are uniformly expressed. However,
Jagged1 is still differentially expressed at P3. But unlike it's
expression at E14 and E17.5, higher expression is
observed along the dorsal aspect (Fig. 6G).
As with the data regarding expression at E14, these pat-
terns indicate the temporally dynamic nature of expres-
Three-dimensional reconstruction of gene expression at  E17.5 Figure 4
Three-dimensional reconstruction of gene expres-
sion at E17.5. A) Gicerin. B) Zinc csl-type containing 3. C) 
Protocadherin17. D) Protocadherin7. E) Jagged1. F) Connective 
tissue growth factor. G) Putative microRNA-containing com-
mon element. H) Examples of in situ hybridization data used 
to create the Jagged1 reconstruction (Fig. 4E). Six coronal 
sections are shown taken from anterior to posterior bulb. 
Dorsal is up and medial is to the right. I) Examples of in situ 
hybridization data used to create the Connective tissue growth 
factor reconstruction (Fig. 4F).
E14 spatial differential expression Figure 5
E14 spatial differential expression. Medial is to the right 
and dorsal is towards the top. A) The putative miRNA is 
expressed strongly in the DL bulb and weakly in the VM 
aspect. B) Gicerin expression at E14 is elevated in the DL bulb 
(arrowhead). C) Connective tissue growth factor expression is 
higher in the DM bulb (arrowhead). D) Jagged1 expression is 
elevated ventrally (arrowhead). E) Protocadherin17 is 
expressed in two distinct layers in the VM mantle (arrow-
head). Expression can also be detected in the DL aspect 
(arrowhead). F) Protocadherin7 is expressed broadly within 
the bulb in a pattern that roughly complements that of 
protocadherin17 (arrowheads), with very low expression 
observed ventromedially. Scale bar = 100 μm.BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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sion by these various genes. Gicerin, for example, is
expressed most highly in the DL bulb at E14, but is DM
and VL in both the E17.5 and P3 bulb. Pcdh17 is VM and
DL at E14, VM at E17, and uniform at P3. We note that,
consistent with our initial observations at E17.5, Zcsl3, the
putative miRNA, Jagged1, Pcdh17, and Pcdh7 expression
can clearly be detected in the EPL, GL, and mitral layers.
Lack of precise colocalization with Tbr1
We have hypothesized that cells within the EPL express
guidance cues for OSNs. Genetic studies using the Tbr1
mutant mouse resulted in the ablation of most projection
neurons in the bulb [7]. Projection neurons include mitral
cells as well as internal and middle tufted cells [1]. As tar-
geting is unaffected in Tbr1 mutant mice, a major problem
has been to determine what cell-types within the bulb
remained that could be important for this process. If our
genes are expressed in cells that provide guidance infor-
mation to OSNs, we would predict that at least some cells
that express our candidate genes do not express Tbr1, and
would not be ablated in the mutant.
Prior studies have shown that Tbr1 is expressed in cells
distributed from the ventricle to the nascent mitral/tufted
layer at E16.5 [42]. We found a similar distribution of
Tbr1-positive cells at E17.5. We performed double-label
experiments with Tbr1 and with our genes to determine
what overlap exists in expression. Zcsl3 is enhanced in
expression laterally (Fig. 7A). In contrast, Tbr1 expression
(green) in this same section is widespread in the granule
and mitral/tufted layer (Fig. 7C), as previously described
[42]. Merging the two images shows that expression of
Zcsl3 occurs in cells that extend into the nascent EPL/GL
which do not express Tbr1 (Fig. 7B). Similarly, Pcdh17 is
Double-label in situ hybridization with Tbr1 Figure 7
Double-label in situ hybridization with Tbr1. Nascent EPL/GL 
is dorsal and the granule layer is ventral in each section. 
Arrowheads in all panels indicate cells that express candidate 
genes but do not express Tbr1. A-C) Zinc finger csl-type con-
taining 3 (Zcsl3) (red)/T-box brain gene 1 (Tbr1) (green). Note 
Zcsl3 expression extends beyond the Tbr1 expression 
domain. D-F) Protocadherin17 (red)/Tbr1 (green). G-I) Typical 
punctate pattern observed using a cDNA probe containing 
the common element (red)/Tbr1 (green)/DAPI (blue). J-L) 
Connective tissue growth factor (red)/Tbr1 (green). M-O) Gicerin 
(red)/Tbr1 (green). Scale bar = 100 μm.
P3 spatial differential expression Figure 6
P3 spatial differential expression. Medial is to the right 
and dorsal is towards the top. A) Gicerin expression in the 
anterior bulb is enhanced in the lateral aspect (arrowheads). 
B) Gicerin expression in the middle bulb displays symmetric 
expression, with increased expression along the DM and VL 
aspects. Weaker expression connects the two domains 
(arrowheads). C) The putative miRNA-containing common 
element appears uniformly distributed in the mitral, external 
plexiform, and glomerular layers. Arrow indicates EPL 
expression. D) Connective tissue growth factor (CTGF) expres-
sion in the anterior bulb is predominantly lateral (arrow-
heads). E) CTGF expression in the middle bulb is uniformly 
distributed. F) Zinc finger csl-type containing 3 (Zcsl3) expres-
sion at P3 is uniform in all aspects of the bulb. G) Jagged1 
expression is differentially expressed in the dorsal aspect of 
the bulb (region between arrowheads). Expression can also 
be observed more peripherally deep to the GL (arrow). H) 
Protocadherin17 expression is uniform in all aspects. Expres-
sion is detected in the mitral and glomerular (arrow) layers. 
I) Protocadherin7 expression is uniform in all aspects of the 
bulb. Similar to protocadherin17, expression is observed in the 
mitral and glomerular (arrow) layers. Scale bar = 200 μm.BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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enhanced in VM cells in the anterior bulb (Fig. 7D). A sub-
set of these cells do not overlap in expression with Tbr1
(Fig. 7E,7F). The putative miRNA identified in our screen
is also expressed in nascent EPL/GL cells that do not
express Tbr1 (Fig. 7G–I). Finally, a subset of CTGF (Fig.
7J–L) and Gicerin (Fig. 7M–O) expression also occurs
within cells that do not express Tbr1. Thus, while overlap
with Tbr1-expressing cells does occur, Tbr1-negative cells
that express our genes are present within the bulb. Per-
haps most interestingly, these Tbr1-negative cells are pri-
marily located in the regions where the differential
expression of our genes appears strongest. For example,
Zcsl3 is spatially differentially expressed in the lateral
bulb, and many of these cells have no detectable Tbr1
expression (Fig. 7B).
Expression of candidate cues are affected in chemically 
ablated mice
While we have shown the existence of a number of genes
demarcating different domains within the bulb, it remains
unknown whether or not they are functionally relevant for
OSN guidance. Unfortunately, no in vitro system exists in
the olfactory system to test this hypothesis, and genetic
analysis has remained the primary means for assessing
function. To more rapidly determine the potential role of
these genes in targeting, we decided to employ a chemical
ablation approach.
The olfactory epithelium is continuously being regener-
ated during adult life. Prior studies have shown that Tyro-
sine hydroxylase (TH) expression is drastically reduced
following intranasal ablation with zinc sulfate [43]. As
regeneration proceeds, TH expression gradually recovers.
Although TH is an intracellular enzyme, it has been pro-
posed that this recovery is dependent upon afferent input
from regenerating OSNs. This process, although poorly
understood, is thought to be a result of transneuronal reg-
ulation of glomerular neurons by OSNs [43].
We decided to ask whether or not this ablation paradigm
could be used to determine whether our candidate genes
are expressed in cells that interact with OSNs. We would
expect that if they were, then their expression, like that of
TH, would change in response to OSN deafferentation.
We ablated OSNs in one nares of eight-week old mice
with a solution of zinc sulfate, leaving the other nares
alone. We determined the success of the ablation based on
expression of OMP in the epithelium. As shown in the
right half of Fig. 8A, at 24 days post-ablation, essentially
no OMP is observed in the ablated epithelium. Small, iso-
lated pockets of OMP  expression were occasionally
detected in some ablated epithelia, presumably due to a
lack of access to these regions by the zinc sulfate solution
(data not shown). By 40 days post-ablation, OMP expres-
sion has started to recover, although this expression is still
somewhat thinner when compared to the control side
(compare right and left halves of Fig. 8B). We did not
examine later timepoints. We found that the rate of OMP
recovery was somewhat variable, with some epithelia
showing OMP expression by 30 days, while others
showed little or no expression. We therefore based our
experiments in the bulb on the pattern of OMP expression
in the epithelium, and not by the number of days post-
ablation.
We found the bulb on the ablated side is smaller as previ-
ously reported [43] due to a significant reduction in the
size of the nerve and glomerular layers (data not shown).
Based on DAPI staining, the number of cells in the
glomerular layer did not appear to be reduced (Fig. 8C–
D), consistent with previous studies showing that little or
no cell death results from the ablation process [43,44]. We
found that GluR1 expression appeared to be reduced in
the glomerular layer and increased in the mitral layer at 24
days (Fig. 8E) but was equal in expression between
ablated and control bulbs by 40 days (Fig. 8F). This is
reminiscent of alterations in GluR1 expression in naris
occluded animals [45]. We confirmed that TH was absent
from the ablated side at 24 days (Fig. 8G) but recovered by
40 days post-ablation (Fig. 8H).
We then tested a subset of our genes on these ablated ani-
mals. Interestingly, we found a variety of different
responses to the ablation. CTGF is expressed in the adult
in the glomerular and mitral layers (Fig. 8I). This expres-
sion is absent in bulbs on the ablated side at 24 days (Fig.
8I) but recovers by 40 days (Fig. 8J). Pcdh7 is expressed in
the glomerular layer in adults, with weaker, more scat-
tered expression in the mitral layer (Fig. 8K). Like CTGF,
both layers are affected in the ablated side at 24 days (Fig.
8K), but expression recovers by 40 days post-ablation (Fig.
8L). Pcdh17 is also expressed in the glomerular and mitral
layers (Fig. 8M). However, in the ablated side, only the
glomerular layer expression of Pcdh17 is affected, while
mitral layer expression remains constant (Fig. 8M).
Expression in the glomerular layer returns to control levels
by 40 days (Fig. 8N). We did not find any differences in
expression for the putative miRNA or Zcsl3 in bulbs in
ablated animals (data not shown). Based on prior studies
showing TH regulation by OSN innervation, we conclude
that several of our genes are likely to be expressed in cells
that interact directly with OSNs.
Pcdh7 and Pcdh17 are expressed in subsets of OSNs
Two of our genes, Pcdh7 and Pcdh17, are members of the
cadherin superfamily. Protocadherins are known to pos-
sess weak homophilic adhesion properties in vitro [46,47].
In one model, protocadherins expressed by OSNs would
bind their cognate partner expressed by nascent EPL/GL
cells within the bulb. The specificity of these interactionsBMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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Expression after chemical ablation Figure 8
Expression after chemical ablation. In all panels, the left half corresponds to the unablated side and the right half corre-
sponds to the ablated side. Panels A, C, E, G, I, K and M correspond to images taken from mice that were sacrificed 24 days 
post-ablation. Panels B, D, F, H, J, L and N correspond to images taken from mice that were sacrificed 40 days post-ablation. A) 
Olfactory marker protein (OMP) expression in the epithelium of 24 day ablated mice. No expression of OMP is observed in the 
epithelium on the ablated side (compare right half (arrow) with left half). B) OMP expression in the epithelium of 40 day ablated 
mice. Recovery of OMP expression has begun on the ablated side (right side), although this expression pattern is thinner and 
less robust than that of control (arrow). C) DAPI staining of bulbs from 24 day ablated mice shows significant reduction in 
glomerular size, but no apparent decrease in cell number. D) DAPI staining of bulbs from 40 day ablated mice show no dra-
matic differences compared to control, although glomerular size still appears somewhat reduced. E) Glutamate receptor subunit 
1 (GluR1) expression in bulbs from 24 day ablated mice. Note stronger glomerular expression of GluR1 on the unablated side 
relative to the ablated side. However, GluR1 expression in the mitral layer was slightly but visibly stronger on the ablated side 
relative to control (arrows). F) GluR1 expression has returned in 40 day ablated animals to levels similar to control. G) Tyrosine 
hydroxylase (TH) expression in 24 day ablated animals is dramatically reduced (arrow). H) TH expression in 40 day ablated ani-
mals. Expression of TH has returned to levels similar to that of control. I) Connective tissue growth factor (CTGF) expression in 24 
day ablated animals. On the unablated side, CTGF is expressed in both the mitral/tufted and glomerular layer. No expression in 
either layer is observed in the ablated animal (arrows). J) CTGF expression in 40 day ablated mice. Expression levels are slightly 
weaker than on the control side but is still clearly visible in mitral and glomerular layers. K) Protocadherin7 (Pcdh7) expression, 
like CTGF, is also detected in the mitral and glomerular layers in adult, although expression in the mitral layer is weak and 
inconsistent. On the ablated side, expression is reduced in both layers, but weak expression is still visible in some cells 
(arrows). L) Pcdh7 expression in 40 day ablated mice. Observed expression of Pcdh7 approximates that of the control bulb. M) 
Pcdh17 expression in 24 day ablated mice. Expression is present in both the mitral and glomerular layers. However, on the 
ablated side, only expression in the glomerular layer is affected (arrow). N) Pcdh17 expression in 40 day ablated mice. Expres-
sion has recovered and approximates that of control. Scale bar = 125 μm (7A-D); 200 μm (7E-N).BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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would contribute towards the final glomerular conver-
gence pattern.
We therefore examined Pcdh7 and Pcdh17 expression in
the epithelium. Interestingly, we found both genes are
expressed in subsets of OSNs (Figs. 9A–B). Double-label
fluorescent  in situ hybridization shows that, although
some cells express both Pcdh17 and Pcdh7, others express
one or the other protocadherin (Fig. 9C). Within the bulb,
fluorescent double-label in situ experiments show a simi-
lar phenotype, as Pcdh7 expression overlaps with that of
Pcdh17, but distinct domains of the bulb are uniquely
labelled with one or the other protocadherin (Fig. 9D).
The expression of these cadherins in both the epithelium
and in the bulb is consistent with a model in which these
molecules contribute towards the establishment of the
topographic map.
Discussion
To our knowledge, no cell-type or gene expressed within
the bulb has been functionally proven to provide spatial
guidance information to OSNs. Sema3A, for example, has
been genetically shown to affect OSN targeting, but this is
due to its expression in ensheathing glia [38] which
migrate to the nerve layer from the epithelium. A number
of genes are uniformly expressed within cells derived from
the bulb (e.g. Sema3A [48]), but it is difficult to under-
stand how, given this uniform expression, these genes
would guide OSN axons to different domains within the
bulb. The lack of viable potential guidance cues has led
instead to genetic approaches that ablated either whole
classes of cell-types within the bulb (e.g. Tbr1; [7]) or
eliminated much of the bulb entirely (e.g. Extratoes; [11]).
The absence of suitable molecular candidates that could
potentially guide OSN axons to subdomains of the bulb
has strongly inhibited any study of the role of the bulb in
guidance.
In contrast, studies manipulating odorant receptor expres-
sion have led to models where the odorant receptor plays
a significant role in guidance [3,4,49]. The recent discov-
ery that the Kirrel 2/3 and Ephrin/Eph A5 expression are
controlled by odorant receptor activity provides new
insight into how receptor choice influences glomerular
positioning. However, in all of these receptor swap exper-
iments, it is clear that the receptor alone does not mediate
all aspects of glomerular targeting. The dorsal-ventral
position of the OSN within the epithelium is thought to
provide position-dependent information as well [9]. But
what genes comprise these position-dependent determi-
nants, and what potential partners are bound by such
determinants are still unknown. Moreover, why OSNs
innervate both a medial and a lateral glomerulus has not
been explained by studies manipulating odorant receptor
expression. The presence of gradients [36] or of mirror-
symmetric expression patterns within the bulb [50] have
been suggested as potential explanations for how topo-
graphic OSN projection patterns are established. How-
ever, considerable disagreement exists over the role of the
bulb in guidance [9].
The role of bulbar projection neurons in guiding OSN
axons has been examined using different genetic para-
digms [7,8]. These studies have suggested that these cells
are not necessary for topographic convergence of OSNs.
While these analyses only examined OSNs that express the
P2 odorant receptor, mitral cell tracing studies also do not
necessarily support a role for these cells in guidance.
Mitral cell dendritic arbors initially are distributed among
several glomeruli, but are refined during the first week of
postnatal development to a single glomerulus [15]. It is
difficult to understand, if mitral cells do indeed express
the primary cues needed for OSN guidance, why such cues
would be distributed among multiple glomeruli initially,
and the dendritic arbor refined only after convergence has
been completed. But despite the fact that these studies
Expression of protocadherin17 and 7in the epithelium Figure 9
Expression of protocadherin17 and 7in the epithelium. A) 
Protocadherin17 (Pcdh17) expression in the OE is localized to 
subsets of cells in the neuronal layer (black arrowheads). 
Expression is also seen in occasional cells in the sustentacular 
and basal layers. B) Protocadherin7 (Pcdh7) expression in the 
epithelium is localized to subsets of cells in the neuronal 
layer (black arrowheads). C) Double-label in situ hybridiza-
tion using Pcdh17 (green) and Pcdh7 (red) as probes. 
Although overlap in expression is occasionally observed, 
most cells express either Pcdh17 (white arrowheads) or 
Pcdh7 (arrows). D) Double-label in situ hybridization experi-
ment showing domains of expression of Pcdh17 (green) and 
Pcdh7 (red) in the anterior bulb. The localized expression of 
Pcdh17 at the VM surface partially overlaps with that of Pcdh7 
(domain between arrows) in anterior bulb. Scale bar =25 μm 
(A,B), 100 μm (C,D).BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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indicate that mitral cells may not play a primary role in
guidance, genetic ablation studies removing the entire
bulb [11] have shown that topographically correct conver-
gence by P2-expressing OSNs does not occur. One inter-
pretion of these results is that other cell-types within the
bulb are important for providing guidance information to
OSNs. We theorized that these cells correspond to those
in the EPL and GL.
In this hypothesis-driven microarray-based experiment,
we show that the nascent EPL/GL of the bulb can be sub-
divided into multiple domains based on the expression of
our identified genes. At E17.5, the first time that conver-
gence is observed [20], the anterior bulb can be distin-
guished molecularly both laterally (CTGF,  Gicerin,
Jagged1) and medially (Jagged1, Pcdh7). In the middle and
posterior bulb, Zcsl3  is expressed in a gradient that
extends from dorsal to ventrolateral, while a probe con-
taining the miR-706 sequence is expressed in a subset of
cells that span a similar region. Perhaps most interest-
ingly, we find that Gicerin,  CTGF, and Jagged1  are
expressed in a symmetric manner. While it is well-known
that OSNs project to medial and lateral glomeruli, the
existence of mirror-symmetric cues has, to date, only been
hypothesized [50]. However, our patterns suggest that this
medial-lateral symmetry is more complex than previously
thought. Gicerin and CTGF are roughly symmetric about
both the DV and ML axes, while Jagged1 appears symmet-
ric only around the ML axis. Thus, each hemi-bulb can be
further distinguished based on dorsal or ventral expres-
sion of Gicerin and CTGF.
Several lines of evidence are consistent with the expres-
sion of these candidate cues within cells of the EPL. First,
we show by counterstaining with DAPI that expression of
these genes does not colocalize precisely with the nascent
mitral layer. Second, we show at P3 and in adult that
many of these genes are expressed in the EPL and GL, con-
sistent with their expression at E17.5 in the nascent EPL/
GL. Finally, we show that there are populations of cells at
E17.5 that express our candidate genes but do not express
Tbr1, a marker for projection neurons. Thus, we have
shown using a variety of approaches that, in addition to
mitral layer expression, nascent EPL/GL cells also express
these genes.
Interestingly, in addition to the fact that not all cells that
express our genes express Tbr1, the cells that do not
express Tbr1 are those that show most clearly the differen-
tial expression patterns observed with our genes. For
example, Pcdh17 is strongly and selectively expressed in a
subset of cells in the VM aspect of the anterior bulb. These
same cells do not express Tbr1. Thus, in Tbr1 mutant ani-
mals, we predict that these cells would not only be
present, but that the observed differential expression pat-
terns would also still be present. These cells may therefore
provide a potential solution to the problem of which cells
within the bulb could express guidance cues important for
OSN guidance.
Mitral cells are known to mature in a medial-to-lateral
fashion from E14–E17 [39], and a rostral-caudal wave of
development occurs during glomerular formation [21].
However, these developmental events cannot readily
explain our various observed patterns. For example,
Gicerin and CTGF are expressed in subsets of cells in the
lateral domain in anterior bulb, while Jagged1 and Pcdh7
are expressed medially. Several of our genes are both
medially and laterally expressed. It seems unlikely that
these patterns can be explained solely on the basis of neu-
ronal maturation events during development.
Are any of our identified cDNAs involved in guiding OSNs
to the bulb? An alternative interpretation would be that
these genes may be important for establishing intrabulbar
circuits. External tufted cells are known to indirectly con-
nect glomeruli innervated by a common population of
OSNs [19]. Thus, these genes may act to establish these
connections. Yet another potential function of these genes
can be suggested based on their expression in the mitral
layer. These genes may act to mediate connectivity
between projection neurons and higher cortical synaptic
partners. Finally, these genes may not be involved in axon
guidance per se, but instead are important for events sur-
rounding synaptogenesis.
To provide support for the hypothesis these genes are
important for guiding OSN axons, we used a chemical
ablation approach [43]. Expression of Tyrosine hydroxylase
(TH) is known to be down-regulated initially in ablated
animals, but reappears as reinnervation of the bulb pro-
ceeds. Thus, TH expression is influenced by OSN innerva-
tion. Similarly, this approach has also been used to study
Sema3A  expression in axotomized bulbs [51]. In these
experiments, normal expression of Sema3A  is greatly
reduced in axotomized bulbs. Expression is instead upreg-
ulated near the site of axotomy. Two months after abla-
tion,  Sema3A  expression reappeared at its normal
location. These results indicate that cells which interact
with OSNs can display molecular alterations in their
expression profile upon deafferentation. We showed that
CTGF, Pcdh17, and Pcdh7 were altered in expression in
response to ablation. Based on prior studies of TH, we
conclude that these genes are expressed in cells that inter-
act with OSNs.
We note that several of our candidate cues correspond to
genes known to be important for guiding axons elsewhere
in the nervous system (Pcdh7,  Pcdh17,  Gicerin), or are
involved in angiogenesis (Jagged1,  CTGF).  CTGF  andBMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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Gicerin are known to mediate cell-cell adhesion in vitro.
Cadherins have been shown to be play multiple roles dur-
ing development, from neurite outgrowth to synaptogen-
esis [52]. The changing patterns of expression of Pcdh7
and  Pcdh17  during development may signal multiple
roles as OSN innervation of the bulb proceeds. Pcdh7 and
Pcdh17 may operate initially as guidance cues based on
their differential expression within the bulb and epithe-
lium. After growth of OSNs into the bulb, they may then
act secondarily in synaptogenesis. While definitive proof
requires genetic manipulation of the individual candi-
dates, these genes provide novel targets that will enable
new approaches towards determining the role of the bulb
in guidance.
Conclusion
We have identified several genes whose expression pat-
terns define various subdomains within the developing
mouse olfactory bulb. We show that these genes are
expressed in cells within the nascent EPL/GL and ML, and
that some of these cells do not express Tbr1. Our regener-
ation paradigm suggests that these genes are expressed in
cells that interact with OSNs. These genes therefore repre-
sent novel candidate guidance cues that may guide OSN
axons to appropriate locations within the bulb.
Methods
Animals
Swiss-Webster mice were used for all experiments. The day
a vaginal plug was observed was day P0.5. All protocols
were approved by the Cornell IACUC.
Laser microdissection and RNA isolation
E17.5 embryos were embedded in 3% agarose and fresh
frozen in isopentane/liquid nitrogen as described [53].
LMD samples were collected into 30 μl of lysis buffer and
RNA isolated using Gentra's PureScript kit. Total RNA
yield was ~ 200 pg/LMD isolate using the Agilent Pico-
Chip Bioanalyzer assay.
RNA amplification
A modified T7 RNA polymerase amplification protocol
was performed using an optimized T7 primer [34]. First-
round aRNA was tailed with poly(A) polymerase, provid-
ing a template for T7-d(T) primer and the generation of a
second round of aRNA. For the arrays, 20% of this aRNA
was amplified a third time, and a portion labeled by prim-
ing with amine-terminal random hexamers and incorpo-
rating a modified amino-allyl dUTP [54]. Hybridizations
were performed in 50% formamide, 3xSSC, 20 mM Tris
8.5, 0.1% SDS, 0.1 μg/μl salmon sperm DNA, and 0.1%
BSA at 45°C using a Tecan HS400 machine and scanned
on an Axon 4000B scanner.
Microarray generation
PCR products from the NIA 15 k [55], 7.4 k [56], and 11
k BMAP (brainEST.eng.uiowa.edu) collections were resus-
pended in 1xSSC/0.005% sarkosyl and printed on Corn-
ing UltraGAPS slides using a custom-built microarrayer
and Telechem 946 pins.
Experimental design. For each section, the four LMD sam-
ples were hybridized directly against one another using a
loop design [see Additional File 1]. The directions of the
loops (clockwise or counter-clockwise) were alternated
along the AP axis to control for dye bias.
Statistical analysis
Background measurements were not subtracted to reduce
variation in weakly expressing genes [57]. Within slide
normalization (print-tip loess) was applied [58] and a
fixed effects linear model was employed to identify spatial
differentially expressed genes [59]. For a typical gene g, the
intensity value corresponding to the four different sub-
regions of the bulb is denoted by DMk,DLk,VMk,VLk,
where k represents the different sections taken along the
AP-axis. The log transformation of these values is defined
as dmk = log2 DMk, dlk = log2 DLk, vmk = log2 VMk and vlk =
log2 VLk. To estimate the spatial gene expression for gene
g, all of the spatial sections along the AP-axis are treated as
replicates and used to fit four separate linear models for
each of the comparisons of interest α1 = dm-dl, α2 = dm-vm,
α3 = vl-dl and α4 = vm-vl . The linear model is written as
Mik = αi + εik
where i = 1,,4 representing the four main comparisons of
interest; Mikis a vector of log-ratios and var(εik) = σi This
model is equivalent to performing four separate series of
one-sample comparisons on four separate sets of data.
Estimates of the coefficient of variation, moderated t-sta-
tistics, and adjusted p-values were calculated using lmFit
in the library limma [59]. Comparison of this model with
other analysis options, as well as gene lists for the individ-
ual groups, are presented as an additional file [see Addi-
tional File 1].
In situ hybridization
Probes were generated from the original clone printed on
the array. Hybridization to sections was essentially as
described [34]. Fixed sections were treated with 10 μg/ml
proteinase K prior to hybridization at 60°C. Double label
in situ hybridization was performed with digoxigenin and
biotin-labeled probes and detected using the Fast Red/
HNPP substrate or the TSA Renaissance kit as per manu-
facturer's instructions. Digoxigenin-labeled locked nucleic
acid (LNA)-oligos from Exiqon were hybridized at 50°C.
Additional clones within the clonesets corresponding to
Pcdh7  (clones H3060E02 and H3067F12) and Pcdh17BMC Developmental Biology 2007, 7:48 http://www.biomedcentral.com/1471-213X/7/48
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(clone AI843903) were used to confirm the observed pat-
tern for these genes. Additional probes for other genes
were produced by cloning various subregions: Jagged1
(nt716–1514 and 3747–4559), Zcsl3  (nt83–1004),
Gicerin  (nt23–1105, 904–2102, 1592–2249, 1993–
2873), CTGF (nt1102–1697, 1686–2267), Tbr1 (nt521–
1122 and nt2798–3398).
Ablation
A solution of 5% zinc sulfate in PBS was injected using a
1 ml hypodermic syringe drawn out to produce a thin,
flexible tube that can be easily inserted into the nares.
Mice were anesthetized with isofluorane prior to instilla-
tion of 50–75 μl of zinc sulfate solution.
Three-dimensional reconstruction
In situ hybridization data from E17.5 coronal sections
were obtained for each gene every 60–80 μm along the AP
extent of the bulb. The expression patterns for multiple
bulbs were compared against one another, and were
found to be similar. We therefore performed reconstruc-
tions using data from an individual bulb hybridized with
any given probe. Images from hybridized sections were
imported into Adobe Photoshop, and regions of high
expression were selected and enhanced. These enhanced
images were combined using ImageJ to create individual
stacks of images corresponding to a given gene. A projec-
tion of the stacked images was then generated to produce
a three-dimensional pattern of gene expression. These
projections were then superimposed upon a cartoon
depiction of the bulb to produce the final image.
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